Trace Neuroscience, a biopharmaceutical launch based in South San Francisco, is targeting the UNC13A protein as a possible treatment path for amyotrophic lateral sclerosis (ALS) and other neurogenerative diseases. In a Nov. 12 press release, the company said UNC13A “is a genetically validated target with the potential to treat 97% of people living with ALS.”…
New Biopharmaceutical Company to Work on UNC13A Protein Cure to ALS
Briefly: Etac Announces R82 Discontinuations; CP Foundation Lists September Clinical Trials
Featuring Etac and the Cerebral Palsy Foundation.
Etac Announces R82 Discontinuations for January 2025 Etac has announced products it will be discontinuing as of Jan. 1, 2025. In a Sept. 20 bulletin, Etac said it will stop offering the Orca bathtub; the Penguin bathtub positioning system; the Cricket manual wheelchair; the stroller-style Stingray manual wheelchair; and the Scallop seating system. Etac will…
‘Healthy Brains’ Act Would Establish Program to Study Environmental Relationship to Neurodegenerative Diseases
H.R. 9233 calls for the National Institutes of Health to create collaborative centers for research.
A bill introduced in the U.S. House of Representatives would establish a research program to study how environmental factors link to neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis, and atypical Parkinsonian disorders, among others. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science…
Philips, World Stroke Organization Urge Better Access to CVA Care
The technology to lessen the impact of cerebrovascular accidents isn’t always accessible.
Royal Philips and the World Stroke Organization (WSO) are partnering to bring greater awareness to the need for best-practice care for patients with cerebrovascular accident (CVA), commonly known as stroke. In a Sept. 10 news announcement, Philips said it is “Time for a revolution in stroke care,” referencing a new policy paper co-published with the…
EverythingALS Launches App for ALS Community
New version of the app will connect people with ALS while collecting data to support research.
EverythingALS, a technology- and data-focused nonprofit, has launched an app to support people living with amyotrophic lateral sclerosis (ALS), their families and caregivers, researchers, and health-care professionals. In a late August news release, Seattle-based EverythingALS said the new app, compatible with iOS and Android devices, “represents a significant upgrade from the previous version, which was…
Briefly: Workshop to Investigate GLP-1R and Nervous System Disorders; ALS Survey Investigates AI Impact on AAC
Featuring the National Academies of Sciences, Engineering, and Medicine; and Boston Children’s Hospital.
NASEM Public Workshop to Discuss Applications of GLP-1R Agonists The National Academies of Sciences, Engineering, and Medicine (NASEM) is hosting a Sept. 10 day-long workshop to discuss the impact of glucagon-like peptide-r receptor (GLP-1R) agonists on central nervous system disorders, including neurodegenerative diseases such as Parkinson’s. The workshop will bring together experts from a number…
New Research Examines Mobility Devices, Patient Characteristics of People Reporting Falls
The study used information from the Functional Mobility Assessment and Uniform Dataset Registry.
New research by clinical investigators at the University of Pittsburgh and the University of South Carolina reports on characteristics of people with limited mobility who experienced falls. An Aug. 19 news announcement from U.S. Rehab said the study — Falls in People with Mobility Limitations: A Cross-Sectional Analysis of a U.S. Registry of Assistive Device…
Study: Speech Neuroprosthesis Demonstrates Quick Setup, Accuracy in ALS Patient
Brain-computer interfaces can be easier to operate than eye-gaze and other systems for people living with paralysis.
A brain-computer speech interface implanted in a patient with amyotrophic lateral sclerosis (ALS) was brought up to speed quickly and demonstrated impressive accuracy, according to a new study in the New England Journal of Medicine (NEJM). The study — “An Accurate and Rapidly Calibrating Speech Neuroprosthesis” — was published by the NEJM on Aug. 14.…
Briefly: Colin Farrell Launches a Foundation; CP Foundation Updates Research Study Opportunities
Featuring the Colin Farrell Foundation and the Cerebral Palsy Foundation.
Actor Colin Farrell Launches Foundation to Support Adults with Intellectual Disabilities Irish actor Colin Farrell has launched the Colin Farrell Foundation, “committed to transforming the lives of individuals and families living with intellectual disability through education, awareness, advocacy and innovative programs.” In an Aug. 7 announcement, the Oscar-nominated actor launched his foundation’s website, which noted…
Inflammation Associated with Nervous System Damage in MS Study
Inflammation caused by common illnesses such as colds can impact the cervical spinal cords of people with multiple sclerosis.
Inflammation that occurs in parts of the body other than the brain and spinal cord has been associated with atrophy in the cervical spinal cord in patients with multiple sclerosis (MS), a new study said. The study — “Systemic inflammation associates with and precedes cord atrophy in progressive multiple sclerosis” — was published this spring…